Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06240312

Optic Nerve Head Strain as Biomarker for Glaucoma

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Accepted

Summary

The investigators will test the hypothesis that images of the optic nerve head taken a 2 different eye pressures will yield strain estimates that are predictive of the course of glaucoma.

Detailed description

Existing glaucoma patients and suitable control adults will be imaged with an FDA-approved optical coherence tomography instrument. Those who are imaged at 2 different eye pressures will generate biomechanical strain estimates. These will be compared to visual field and retinal nerve fiber layer measurements over time. The investigators expect that baseline strain and their changes over time will be associated with progression rate of glaucoma damage, providing a biomarker for susceptibility.

Conditions

Interventions

TypeNameDescription
DEVICEImages of eye at 2 eye pressuressubject images of the eye's optic nerve head are studied

Timeline

Start date
2024-07-01
Primary completion
2028-01-31
Completion
2028-01-31
First posted
2024-02-05
Last updated
2025-06-15

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06240312. Inclusion in this directory is not an endorsement.

Optic Nerve Head Strain as Biomarker for Glaucoma (NCT06240312) · Clinical Trials Directory